| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-18144-8_18 |
| P698 | PubMed publication ID | 26162844 |
| P50 | author | Yu Zhao | Q82804403 |
| P2093 | author name string | Ming Xian | |
| Armando Pacheco | |||
| P2860 | cites work | H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response | Q24299859 |
| Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions | Q24301813 | ||
| Crucial role of copper in detection of metal-coordinating odorants | Q24622965 | ||
| Hydrogen sulfide mediates the vasoactivity of garlic | Q24673752 | ||
| Hydrogen sulfide chemical biology: pathophysiological roles and detection | Q26824672 | ||
| Anti-cancer activity of new designer hydrogen sulfide-donating hybrids | Q26825705 | ||
| H2S induces a suspended animation-like state in mice | Q28246406 | ||
| Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice | Q28481347 | ||
| 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain | Q28513550 | ||
| Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R | Q28576521 | ||
| Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation. | Q30492583 | ||
| Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice | Q30497008 | ||
| Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis | Q33356344 | ||
| Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis | Q33665840 | ||
| Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species | Q33771832 | ||
| Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca²⁺-activated K⁺ channels and smooth muscle Ca²⁺ sparks | Q33816504 | ||
| Novel insights into hydrogen sulfide--mediated cytoprotection. | Q33830124 | ||
| The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo | Q33942063 | ||
| H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? | Q33954567 | ||
| Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? | Q48034814 | ||
| S-Allyl-L-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signal-regulated kinase | Q48406862 | ||
| S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction | Q48484730 | ||
| S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia | Q48960370 | ||
| Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. | Q53587374 | ||
| New biologically active hydrogen sulfide donors. | Q54782602 | ||
| Biochemical insight into physiological effects of H2S: reaction with peroxynitrite and formation of a new nitric oxide donor, sulfinyl nitrite | Q56971571 | ||
| Thioglycine and l-thiovaline: Biologically active H2S-donors | Q60695399 | ||
| Gastrointestinal Safety and Anti-Inflammatory Effects of a Hydrogen Sulfide–Releasing Diclofenac Derivative in the Rat | Q60695408 | ||
| 5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity | Q60695409 | ||
| Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro | Q67516125 | ||
| Evidence for thiol-dependent production of oxygen radicals by 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione (oltipraz) and 3H-1,2-dithiole-3-thione: possible relevance to the anticarcinogenic properties of 1,2-dithiole-3-thiones | Q73186317 | ||
| S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions | Q79419961 | ||
| Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation | Q80809383 | ||
| S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway | Q80980892 | ||
| Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest | Q82231964 | ||
| Passive loss of hydrogen sulfide in biological experiments | Q82362478 | ||
| Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma | Q83132279 | ||
| Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study | Q83937008 | ||
| Development of a highly selective fluorescence probe for hydrogen sulfide | Q85096669 | ||
| S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics | Q87370467 | ||
| Design and synthesis of polymeric hydrogen sulfide donors | Q88106978 | ||
| Prevention of liver damage by aged garlic extract and its components in mice | Q105373940 | ||
| Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. | Q34020719 | ||
| Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols | Q34032571 | ||
| Hydrogen sulfide as a gasotransmitter | Q34248391 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model | Q34256975 | ||
| H₂S signalling through protein sulfhydration and beyond | Q34287129 | ||
| AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro | Q34477537 | ||
| Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress | Q34580841 | ||
| Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. | Q34751757 | ||
| Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery | Q35001796 | ||
| Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis | Q35048409 | ||
| Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo | Q35181925 | ||
| Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats | Q35200575 | ||
| Endogenous production of hydrogen sulfide in mammals | Q35819602 | ||
| A practical look at the chemistry and biology of hydrogen sulfide | Q35929034 | ||
| Hydrogen sulfide in biochemistry and medicine | Q35929408 | ||
| Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis | Q36052635 | ||
| NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals | Q36176425 | ||
| Molecular pathophysiology of Parkinson's disease | Q36196507 | ||
| Carbon monoxide (CO) and hydrogen sulfide (H(2)S) in hypoxic sensing by the carotid body | Q36253298 | ||
| Clarifying the real bioactive constituents of garlic | Q36399272 | ||
| Sulfhydration mediates neuroprotective actions of parkin | Q36756670 | ||
| Hydrogen sulphide and its therapeutic potential | Q36975742 | ||
| Role of garlic in the prevention of ischemia-reperfusion injury. | Q36983870 | ||
| Dithiolethiones for cancer chemoprevention: where do we stand? | Q37002516 | ||
| Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury | Q37097747 | ||
| Persulfide reactivity in the detection of protein s-sulfhydration. | Q37101328 | ||
| Synthesis and evaluation of phosphorodithioate-based hydrogen sulfide donors. | Q37213154 | ||
| Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides | Q37233345 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Hydrogen sulfide: a gasotransmitter of clinical relevance | Q37511893 | ||
| Anti-inflammatory agents as cancer therapeutics | Q37709556 | ||
| H2S relaxes isolated human airway smooth muscle cells via the sarcolemmal K(ATP) channel | Q37730872 | ||
| Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals | Q37749789 | ||
| Hydrogen sulfide: neurophysiology and neuropathology. | Q37784819 | ||
| Hydrogen sulfide and cell signaling. | Q37826422 | ||
| Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury | Q37888334 | ||
| Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools | Q37917815 | ||
| Therapeutic potential of new hydrogen sulfide-releasing hybrids. | Q37960619 | ||
| Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications | Q37965571 | ||
| Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
| Evolutionary and comparative aspects of nitric oxide, carbon monoxide and hydrogen sulfide | Q38006568 | ||
| Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives | Q38017235 | ||
| Hydrogen sulphide: novel opportunity for drug discovery | Q38051531 | ||
| Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras | Q38056004 | ||
| Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review | Q38068081 | ||
| Chemical aspects of hydrogen sulfide measurements in physiological samples | Q38114680 | ||
| Chemical foundations of hydrogen sulfide biology | Q38121347 | ||
| Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications. | Q38229082 | ||
| Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. | Q39718802 | ||
| Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria | Q39784182 | ||
| An open trial of high-dosage antioxidants in early Parkinson's disease | Q41176911 | ||
| Detection of protein S-sulfhydration by a tag-switch technique. | Q41806978 | ||
| Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide | Q41990618 | ||
| Cysteine-activated hydrogen sulfide (H2S) donors. | Q42005921 | ||
| Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat | Q42122753 | ||
| Light-induced hydrogen sulfide release from "caged" gem-dithiols. | Q42160193 | ||
| Pharmacological profile of a novel H(2)S-releasing aspirin | Q42804885 | ||
| Thiol-activated gem-dithiols: a new class of controllable hydrogen sulfide donors. | Q42865592 | ||
| Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. | Q42913506 | ||
| Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein | Q43129743 | ||
| A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
| The toxicity of hydrogen sulphide and other sulphides | Q44460706 | ||
| Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative | Q44706021 | ||
| Hydrogen sulfide protects neurons from oxidative stress | Q44904699 | ||
| Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. | Q45061684 | ||
| A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa | Q45087241 | ||
| Hydrogen sulphide vasodilates human pulmonary arteries: a possible role in pulmonary hypertension? | Q45104314 | ||
| Role of hydrogen sulfide in acute pancreatitis and associated lung injury | Q45238727 | ||
| Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. | Q45947130 | ||
| S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. | Q45957950 | ||
| Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. | Q45970576 | ||
| Hydrogen sulphide is pro-inflammatory in haemorrhagic shock | Q46182818 | ||
| Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse | Q46465914 | ||
| Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages | Q46508139 | ||
| The possible role of hydrogen sulfide as an endogenous neuromodulator. | Q46606180 | ||
| Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 | ||
| Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury | Q46626531 | ||
| Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice | Q46718598 | ||
| P304 | page(s) | 365-388 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Handbook of experimental pharmacology | Q26841924 |
| P1476 | title | Medicinal Chemistry: Insights into the Development of Novel H2S Donors | |
| P478 | volume | 230 |
| Q38658612 | A Novel Esterase-sensitive Prodrug Approach for Controllable Delivery of Persulfide Species |
| Q38730945 | Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor. |
| Q47430972 | Chemical Biology of H2S Signaling through Persulfidation |
| Q88491124 | Cysteine-activated hydrogen sulfide (H2S) delivery through caged carbonyl sulfide (COS) donor motifs |
| Q64992903 | Fluorogenic hydrogen sulfide (H2S) donors based on sulfenyl thiocarbonates enable H2S tracking and quantification. |
| Q38806800 | Hydrogen Sulfide Donors Activated by Reactive Oxygen Species |
| Q40211005 | Hydrogen Sulfide: A Novel Player in Airway Development, Pathophysiology of Respiratory Diseases and Antiviral Defenses |
| Q48051045 | Kinetic Insights into Hydrogen Sulfide Delivery from Caged-Carbonyl Sulfide Isomeric Donor Platforms. |
| Q39455710 | Phosphonothioate-Based Hydrogen Sulfide Releasing Reagents: Chemistry and Biological Applications |
| Q49706717 | Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity |
| Q87088527 | Role of Nitric Oxide and Hydrogen Sulfide in the Vasodilator Effect of Ursolic Acid and Uvaol from Black Cherry Prunus serotina Fruits |
| Q38796774 | Sulphurous Mineral Waters: New Applications for Health |
| Q37420836 | The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro |
| Q54215265 | Thiol-Activated Hydrogen Sulfide Donors Antiviral and Anti-Inflammatory Activity in Respiratory Syncytial Virus Infection. |
| Q39152370 | Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues. |
| Q39113984 | Vascular biology of hydrogen sulfide |
Search more.